Expand RARE Menu
RARE MENU

RARE Stock Posts


Unusual Option Volume

RARE Ultragenyx Pharmaceutical23.90-0.21 (-0.9%)

Ultragenyx Pharmaceutical trades 2,062 contracts. The highest volume is in the 16-Jan-26 22.5 puts. News: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Unusual Option Volume

RARE Ultragenyx Pharmaceutical22.96-0.25 (-1.1%)

Ultragenyx Pharmaceutical trades 3,092 contracts. The highest volume is in the 16-Jan-26 22.5 puts.
Unusual Option Volume

RARE Ultragenyx Pharmaceutical23.48+0.48 (+2.1%)

Ultragenyx Pharmaceutical trades 2,934 contracts.
Unusual Option Volume

RARE Ultragenyx Pharmaceutical21.66+1.94 (+9.8%)

Ultragenyx Pharmaceutical trades 2,826 contracts.
Unusual Option Volume

RARE Ultragenyx Pharmaceutical19.97-14.22 (-41.6%)

Ultragenyx Pharmaceutical trades 5,572 contracts. The company has the following event: Phase 3 Orbit and Cosmic Results Announcement for Setrusumab (UX143) in Osteogenesis Imperfecta on Dec 29, 2025. News: Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta
RARE #UltragenyxPharmaceutical stock declines -47.5% in premarket,

Premarket Decliner

RARE Ultragenyx Pharmaceutical34.19-0.39-1.1%

Premarket:17.95-16.24 (-47.5%)

Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Globe NewswireMon, 29-Dec 8:30 AM

Market Data Delayed 15 Minutes